— Know what they know.
Not Investment Advice
Also trades as: CAMX.ST (STO) · $vol 7M · 0RD1.L (LSE) · $vol 2M

CAMRF OTC

Camurus AB
1W: +0.0% 1M: -3.5% 3M: +14.3% YTD: -8.0% 1Y: -10.3% 3Y: +183.1% 5Y: +378.7%
$61.75
+0.00 (+0.00%)
 
OTC · Healthcare · Biotechnology · Tech Score Sell · Power 46 · $3.7B mcap · 39M float · 0.0003% daily turnover · Short 80% of daily vol

Cash Flow Trends

Operating Cash Flow
$869M +124.1% ▲
Capital Expenditures
$139M -371.6% ▼
5Y CAGR: +110.8%
Free Cash Flow
$731M +103.8% ▲
Dividends Paid
$0 +0.0% ▲
Buybacks
$76K +0.0% ▲
Net Change in Cash
$873M -47.5% ▼

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
— Operating Activities —
Net Income-$111M$72M$526M$469M$874M
Depreciation & Amort.$13M$13M$14M$15M$25M
Stock-Based Comp.$13M$39M$103M$35M-$3M
Change in Working Capital-$53M-$18M-$44M-$205M-$58M
Other Non-Cash Items$858K$3M$9M$74M$31M
Operating Cash Flow-$143M$101M$607M$388M$869M
— Investing Activities —
Capital Expenditures-$5M-$2M-$9M-$28M-$138M
Acquisitions (Net)$0$0$0$0$0
Investment Purchases$0$0$0$0$0
Investment Sales$0$0$0$0$0
Other Investing-$952K$7M-$937K-$2M-$640K
Investing Cash Flow-$5M$5M-$10M-$29M-$139M
— Financing Activities —
Net Debt Issuance$0$0$0-$11M$0
Stock Repurchased$0$0$0-$76K-$76K
Dividends Paid$0$0$0$0$0
Other Financing-$7M-$15M-$4M-$157K-$18M
Financing Cash Flow$99M$44M$29M$1.3B$158M
Net Change in Cash-$50M$154M$624M$1.7B$873M
Cash End of Period$412M$566M$1.2B$2.9B$3.7B
Free Cash Flow-$148M$99M$597M$359M$731M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms